India to United States: Fenofibrate Export Trade Route
India has recorded 1,021 verified shipments of Fenofibrate exported to United States, representing a combined trade value of $24.7M USD. This corridor is served by 20 active Indian exporters, with an average shipment value of $24.2K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 13% of total export value with 207 shipments worth $3.3M USD. On the buying side, LIFESTAR PHARMA LLC is the largest importer in United States with $3.3M USD in purchases. The top 3 suppliers — CIPLA LIMITED, MANKIND PHARMA LIMITED, MYLAN LABORATORIES LIMITED — together control 35% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Fenofibrate corridor is one of India's established pharmaceutical export routes, with 1,021 shipments documented worth a combined $24.7M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 13% of all export value, reflecting the consolidated nature of India's fenofibrate manufacturing sector.
Across 20 active suppliers, the average shipment value stands at $24.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 25.0%, placing it at rank #5 among India's top fenofibrate export destinations globally.
On the import side, key buyers of Indian fenofibrate in United States include LIFESTAR PHARMA LLC, CIPLA USA INC UPS SUPPLY CHAIN SOLU, DIRECT CUSTOMER SOLUTIONS LLC and 51 others. LIFESTAR PHARMA LLC is the single largest importer with 210 shipments valued at $3.3M USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#5
- Annual growth+25.0%
- Demand growth+21.1%
- Regulatory ease66/100
Top 10 Indian Fenofibrate Exporters to United States
Showing top 10 of 20 Indian suppliers exporting Fenofibrate to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $16.0K per shipment | 207 | $3.3M | 13.4% |
| 2 | MANKIND PHARMA LIMITED Avg $14.3K per shipment | 200 | $2.9M | 11.6% |
| 3 | MYLAN LABORATORIES LIMITED Avg $38.1K per shipment | 67 | $2.6M | 10.3% |
| 4 | AJANTA PHARMA LIMITED Avg $29.9K per shipment | 71 | $2.1M | 8.6% |
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $47.6K per shipment | 42 | $2.0M | 8.1% |
| 6 | HETERO LABS LIMITED Avg $11.1K per shipment | 139 | $1.5M | 6.3% |
| 7 | V-ENSURE PHARMA TECHNOLOGIES PRIVATE LIMITED Avg $203.0K per shipment | 7 | $1.4M | 5.8% |
| 8 | HETERO LABS LIMITED Avg $27.3K per shipment | 50 | $1.4M | 5.5% |
| 9 | ALEMBIC PHARMACEUTICALS LIMITED Avg $10.6K per shipment | 105 | $1.1M | 4.5% |
| 10 | LUPIN LIMITED Avg $115.2K per shipment | 9 | $1.0M | 4.2% |
This table shows the top 10 of 20 Indian companies exporting fenofibrate to United States, ranked by total trade value. The listed exporters are: CIPLA LIMITED, MANKIND PHARMA LIMITED, MYLAN LABORATORIES LIMITED, AJANTA PHARMA LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, HETERO LABS LIMITED, V-ENSURE PHARMA TECHNOLOGIES PRIVATE LIMITED, HETERO LABS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, LUPIN LIMITED. CIPLA LIMITED is the dominant supplier with 207 shipments worth $3.3M USD, giving it a 13% market share. The top 3 suppliers together account for 35% of the total trade value on this route.
Showing top 10 of 20 total Indian exporters on the India to United States Fenofibrate export route.
Top 10 Fenofibrate Importers in United States
Showing top 10 of 54 known buyers in United States receiving Fenofibrate shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian fenofibrate in United States include LIFESTAR PHARMA LLC, CIPLA USA INC UPS SUPPLY CHAIN SOLU, DIRECT CUSTOMER SOLUTIONS LLC, MYLAN PHARMACEUTICALS INC, AMNEAL PHARMACEUTICALS, LLC (KY), among 54 total buyers. The largest importer is LIFESTAR PHARMA LLC, accounting for $3.3M USD across 210 shipments — representing 13% of all fenofibrate imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LIFESTAR PHARMA LLC | 210 | $3.3M | 13.5% |
| 2 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 157 | $2.2M | 8.9% |
| 3 | DIRECT CUSTOMER SOLUTIONS LLC | 10 | $2.1M | 8.5% |
| 4 | MYLAN PHARMACEUTICALS INC | 38 | $1.2M | 4.9% |
| 5 | AMNEAL PHARMACEUTICALS, LLC (KY) | 27 | $1.2M | 4.9% |
| 6 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 50 | $1.1M | 4.5% |
| 7 | TO THE ORDER OF.... | 72 | $1.1M | 4.3% |
| 8 | MYLAN PHARMACEUTICALS INC, | 22 | $995.2K | 4.0% |
| 9 | ANIP ACQUISITION COMPANY | 19 | $825.3K | 3.3% |
| 10 | Lupin Pharmaceutical Inc | 5 | $746.0K | 3.0% |
Showing top 10 of 54 Fenofibrate importers in United States on this route.
Top 10 Fenofibrate Formulations Imported by United States
Showing top 10 of 472 product formulations shipped on the India to United States Fenofibrate route, ranked by trade value
United States imports a wide range of fenofibrate formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — FENOFIBRATE TABLET — accounts for $1.0M USD across 65 shipments. There are 472 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FENOFIBRATE TABLET | 65 | $1.0M | 4.1% |
| 2 | FENOFIBRATE 145MG TABLET | 26 | $583.1K | 2.4% |
| 3 | FENOFIBRATE CAPSULES USP 134 MG | 6 | $536.4K | 2.2% |
| 4 | FENOFIBRATE TAB USP 48MG 90 UNCOAT USA. | 3 | $504.8K | 2.0% |
| 5 | FENOFIBRATE TAB USP 145MG 90S UNCOAT USA | 5 | $502.1K | 2.0% |
| 6 | FENOFIBRATE CAP 134MG 100 | 2 | $392.2K | 1.6% |
| 7 | FENOFIBRATE TABLETS USP 160MG NDC 60219 5522 9 FDA PRODUCT CODE 61 J D A 09 ANDA 076509 UNIT PACK 90 | 4 | $342.4K | 1.4% |
| 8 | FENOFIBRATE TABLETS USP 120 MG NATIONALDRUG CODE 82619-102-01 BATCH NO.V40042 PACK SIZE:1 x 90's | 1 | $331.6K | 1.3% |
| 9 | Fenofibrate Tablets USP 120 Mg Batch V50083 National Drug Code 82619 102 01 Pack 1 x 90 s | 1 | $330.7K | 1.3% |
| 10 | FENOFIBRATE TABLETS USP 160 MG 500'S Bat | 16 | $326.5K | 1.3% |
Showing top 10 of 472 Fenofibrate formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 152 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's fenofibrate exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 207 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 20 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, MANKIND PHARMA LIMITED, MYLAN LABORATORIES LIMITED — together account for 35% of total trade value on this route. The average shipment value of $24.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as fenofibrate 145mg tablet and fenofibrate capsules usp 134 mg, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LIFESTAR PHARMA LLC is the largest importer with 210 shipments worth $3.3M USD — representing 13% of all fenofibrate imports from India on this route. A total of 54 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $24.7M
- Avg. Shipment
- $24.2K
- Suppliers
- 20
- Buyers
- 54
- Transit (Sea)
- ~15 days
- Annual Growth
- +25.0%
Related Analysis
Reverse Direction
United States → India — Fenofibrate (Import)Other Fenofibrate Routes
Fenofibrate — Export Intelligence Video
Visual overview of India's fenofibrate India to United States export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United States Fenofibrate Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1,021 shipments on this route.
Frequently Asked Questions — India to United States Fenofibrate Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Fenofibrate to United States?
The leading Indian exporters of Fenofibrate to United States are CIPLA LIMITED, MANKIND PHARMA LIMITED, MYLAN LABORATORIES LIMITED. CIPLA LIMITED holds the largest market share at approximately 13% of total trade value on this route.
Q What is the total value of Fenofibrate exports from India to United States?
India exports Fenofibrate to United States worth approximately $24.7M USD across 1,021 recorded shipments. The average value per shipment is $24.2K USD.
Q Which ports does India use to ship Fenofibrate to United States?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 152 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to United States for Fenofibrate?
The average transit time for Fenofibrate shipments from India to United States is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Fenofibrate trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.0% with demand growth tracking at 21.1%. The route is ranked #5 among India's top Fenofibrate export destinations globally.
Q How many suppliers are active on the India to United States Fenofibrate route?
There are currently 20 active Indian suppliers exporting Fenofibrate to United States. The market is moderately concentrated with CIPLA LIMITED accounting for 13% of total shipment value.
Q Who are the main importers of Fenofibrate from India in United States?
The leading importers of Indian Fenofibrate in United States include LIFESTAR PHARMA LLC, CIPLA USA INC UPS SUPPLY CHAIN SOLU, DIRECT CUSTOMER SOLUTIONS LLC, MYLAN PHARMACEUTICALS INC, AMNEAL PHARMACEUTICALS, LLC (KY). LIFESTAR PHARMA LLC is the largest buyer with 210 shipments worth $3.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Fenofibrate.
- 2.Supplier/Buyer Matching: 20 Indian exporters and 54 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1,021 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,021 Verified Shipments
20 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists